[go: up one dir, main page]

SK279730B6 - Iazínu a jehofarmaceuticky a veterinárne prijateľn - Google Patents

Iazínu a jehofarmaceuticky a veterinárne prijateľn Download PDF

Info

Publication number
SK279730B6
SK279730B6 SK1534-94A SK153494A SK279730B6 SK 279730 B6 SK279730 B6 SK 279730B6 SK 153494 A SK153494 A SK 153494A SK 279730 B6 SK279730 B6 SK 279730B6
Authority
SK
Slovakia
Prior art keywords
inducing agent
compound
drug
tolerance
dependency
Prior art date
Application number
SK1534-94A
Other languages
English (en)
Slovak (sk)
Other versions
SK153494A3 (en
Inventor
Meire Nakamura-Craig
Original Assignee
The Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929212495A external-priority patent/GB9212495D0/en
Priority claimed from GB939308654A external-priority patent/GB9308654D0/en
Application filed by The Wellcome Foundation Ltd filed Critical The Wellcome Foundation Ltd
Publication of SK153494A3 publication Critical patent/SK153494A3/sk
Publication of SK279730B6 publication Critical patent/SK279730B6/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK1534-94A 1992-06-12 1993-06-11 Iazínu a jehofarmaceuticky a veterinárne prijateľn SK279730B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929212495A GB9212495D0 (no) 1992-06-12 1992-06-12
GB939308654A GB9308654D0 (en) 1993-04-27 1993-04-27 Therapeutic triazine compounds and use
PCT/GB1993/001243 WO1993025207A1 (en) 1992-06-12 1993-06-11 Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine isethionate for the treatment and prevention of dependence, tolerance and sensitization of drugs

Publications (2)

Publication Number Publication Date
SK153494A3 SK153494A3 (en) 1996-01-10
SK279730B6 true SK279730B6 (sk) 1999-02-11

Family

ID=26301060

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1534-94A SK279730B6 (sk) 1992-06-12 1993-06-11 Iazínu a jehofarmaceuticky a veterinárne prijateľn

Country Status (23)

Country Link
US (1) US5801171A (no)
EP (1) EP0644763B1 (no)
JP (1) JP3439211B2 (no)
KR (1) KR100268823B1 (no)
AT (1) ATE147980T1 (no)
AU (1) AU688729B2 (no)
CA (1) CA2137782A1 (no)
CZ (1) CZ284061B6 (no)
DE (1) DE69307705T2 (no)
DK (1) DK0644763T3 (no)
ES (1) ES2097516T3 (no)
GB (1) GB2282326A (no)
GR (1) GR3022671T3 (no)
HR (1) HRP930964B1 (no)
IL (1) IL105986A (no)
MY (1) MY109330A (no)
NO (1) NO306451B1 (no)
NZ (1) NZ253260A (no)
SI (1) SI9300318A (no)
SK (1) SK279730B6 (no)
TW (1) TW284689B (no)
WO (1) WO1993025207A1 (no)
YU (1) YU48573B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726987D0 (en) 1997-12-22 1998-02-18 Glaxo Group Ltd Compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK153787C (da) * 1979-06-01 1989-01-16 Wellcome Found Analogifremgangsmaade til fremstilling af substituerede 3,5-diamino-6-phenyl-1,2,4-triaziner og alfa-cyanobenzyliden-aminoguanidinforbindelser til anvendelse som mellemprodukter herved
GB8613183D0 (en) * 1986-05-30 1986-07-02 Wellcome Found Triazine salt
GB9012312D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds

Also Published As

Publication number Publication date
NO944790L (no) 1994-12-09
NO306451B1 (no) 1999-11-08
YU48573B (sh) 1998-12-23
JP3439211B2 (ja) 2003-08-25
YU41093A (sh) 1996-10-09
ES2097516T3 (es) 1997-04-01
KR950701814A (ko) 1995-05-17
GB9423697D0 (en) 1995-01-11
JPH07507790A (ja) 1995-08-31
AU4345293A (en) 1994-01-04
DE69307705D1 (de) 1997-03-06
NO944790D0 (no) 1994-12-09
CZ284061B6 (cs) 1998-08-12
DE69307705T2 (de) 1997-05-22
IL105986A0 (en) 1993-10-20
ATE147980T1 (de) 1997-02-15
EP0644763B1 (en) 1997-01-22
TW284689B (no) 1996-09-01
WO1993025207A1 (en) 1993-12-23
EP0644763A1 (en) 1995-03-29
CA2137782A1 (en) 1993-12-23
AU688729B2 (en) 1998-03-19
CZ312894A3 (en) 1995-07-12
GB2282326A (en) 1995-04-05
MY109330A (en) 1997-01-31
GR3022671T3 (en) 1997-05-31
HRP930964A2 (en) 1996-02-29
KR100268823B1 (ko) 2000-12-01
NZ253260A (en) 1997-05-26
US5801171A (en) 1998-09-01
SI9300318A (en) 1994-03-31
SK153494A3 (en) 1996-01-10
DK0644763T3 (da) 1997-07-28
IL105986A (en) 1998-12-06
HRP930964B1 (en) 2000-06-30

Similar Documents

Publication Publication Date Title
DE69431568T2 (de) Inhibierung der migration und proliferation glatter muskeln mit hydroxycarbazolverbindungen
EP0005636A1 (en) Method and product for inducing anorexia
Seidel et al. Alpha-2 adrenergic modulation of sleep: time-of-day-dependent pharmacodynamic profiles of dexmedetomidine and clonidine in the rat.
WO1989005642A1 (en) Dextrorphan potentiator for anticonvulsant composition and method
US5712277A (en) Use of 3,5-diamino-6-(2,3-dichlororophenyl) -1,2,4-triazine for the treatment of pain and oedema
JPH05132430A (ja) 薬物従属症及び禁断症状の治療に関するグリシン/nmdaレセプターリガンドの用法
EP1295599A1 (en) Method for the treatment of prevention of atopic dermatitis
SK279730B6 (sk) Iazínu a jehofarmaceuticky a veterinárne prijateľn
US4312879A (en) Clonidine and lofexidine as antidiarrheal agents
EA000531B1 (ru) Активное вещество при производстве фармацевтического препарата для лечения травматического повреждения головного мозга
US4241087A (en) Dysmenorrhea treatment
HU197512B (en) Process for producing pharmaceutical comprising bromocriptine and suitable for treating drug-habituation
US20030100565A1 (en) Method for the treatment or prevention of atopic dermatitis
JP3633618B2 (ja) 不安緩解剤としてのトリアジン化合物の使用
DE19622866C2 (de) Verwendung von Opiat-Antagonisten und -Agonisten enthaltende Präparationen zur Prophylaxe und therapeutischen Behandlung von Migräne und Migräne-verwandten Erkrankungen
US20230165852A1 (en) Method for treating central nervous system disorders using dopamine d3 partial agonists
AU618325B2 (en) Improvements in or relating to organic compounds
JP3713271B6 (ja) 3,5−ジアミノ−6−(2,3−ジクロロフェニル)−1,2,4−トリアジンの浮腫および痛みの治療のための使用
AU539364B2 (en) Dysmenorrhea treatment
Spector Management of chronic idiopathic urticaria
Buschmann et al. Use of sodium channel blockers for the treatment of preterm labor
JPS6159289B2 (no)